The effects of valerian on the time course of emergence from general anesthesia in Sprague-Dawley rats (Rattus norvegicus)

AANA Journal

Volumn 75, Issue 6, 2007, Pages 431-435

  Chaplin Jr , Robert L ^a   Jedynak, Jeffrey ^a   Johnson, David ^b   Heiter, Donna ^a   Shovelton, Lawrence ^c   Garrett, Normalynn ^a,d  

^a Keesler Air Force Base ^*

^b KEESLER MEDICAL CENTER   (United States)

^c USAF   (United States)

^d BAYLOR UNIVERSITY   (United States)

Author keywords

Benzodiazepines; Emergence; Rats; Valerian

Indexed keywords

ISOFLURANE; MIDAZOLAM; VALERIAN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENERAL ANESTHESIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LAPAROTOMY; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT;

ADJUVANTS, ANESTHESIA; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ANIMALS; HERB-DRUG INTERACTIONS; ISOFLURANE; MALE; MIDAZOLAM; NURSE ANESTHETISTS; PLANT PREPARATIONS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VALERIAN;

EID: 37249089761     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Adusumilli PS, Ben-Porat L, Pereira M, Roesler D, Leitman IM. The prevalence and predictors of herbal medicine use in surgical patients. J Am Coll Surg. 2004;198:583-590.
2. Bovill JG. Adverse drug interaction in anesthesia. J Clin Anesth. 1997;9(suppl):3S-13S.
3. Plushner SL. Valerian: Valeriana officinalis. Am J Health Syst Pharm. 2000;57:328, 333, 335.
4. Houghton PJ. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol. 1999;51:505-512.
5. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569-1575.
6. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 4th ed. Boston, MA: Allyn and Bacon; 2001:57-85.
7. Marder M, Viola H, Wasowski C, Fernandez S, Medina JH, Paladini AC. 6-Methylapigenin and hesperinin: new Valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav. 2003;75:537-545.
8. Sakamoto T, Mitani Y, Nakajima K. Psychological effects of Japanese valerian root extract. Chem Pharm Bull (Tokyo). 1992;40:758-761.
9. Leuschner J, Muller J, Rudmann M. Characterisation of the central nervous system depressant activity of a commercially available valerian root extract. Arzneimittelforschung. 1993;43:638-641.
10. Stoelting RK, Hillier SC. Pharmacology & Physiology in Anesthetic Practice. Philadelphia, PA: Lippincott-Raven Publishers; 1999.
11. Cropley M, Cave Z, Ellis J, Middleton RW. Effect of kava and valerian on human psychological responses to mental stress assessed under laboratory conditions. Phytother Res. 2002;16:23-27.
12. Ziegler G, Ploch M, Miettinen-Baumann D, Collet W. Efficacy and tolerability of valerian extract LI156 compared with oxazepam in the treatment of non-organic insomnia: a randomized, double-blind, comparative clinical study. Eur J Med Res. 2002;7:480-486.
13. Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L) improves sleep quality in man. Pharmacol Biochem Behav. 1982;17:65-71.
14. Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000;33:47-53.